The US has approved lenacapavir for HIV prevention. However, experts worry that cuts to the health budget will "squander" the drug's chance of reducing infections.

The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...

A twice-yearly injectable drug, lenacapavir, hailed as a breakthrough in HIV prevention, could be available in Canada by ...

Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

World leaders are dismantling global health programs and cutting back foreign aid. Will an extraordinary new medicine be able ...

The U.S. has approved the world's only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

A newly approved HIV medication provides near-total protection against infection with just two injections a year. It's called Lenacapavir. But the high price of the drug could limit its reach.

The FDA recently approved Gilead’s drug, lenacapavir, a powerful HIV prevention drug that only requires two shots a year. The O’Neill Institute for National and Global Health Law issued the ...

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...

Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.